[go: up one dir, main page]

DE3575719D1 - Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon. - Google Patents

Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon.

Info

Publication number
DE3575719D1
DE3575719D1 DE8585730094T DE3575719T DE3575719D1 DE 3575719 D1 DE3575719 D1 DE 3575719D1 DE 8585730094 T DE8585730094 T DE 8585730094T DE 3575719 T DE3575719 T DE 3575719T DE 3575719 D1 DE3575719 D1 DE 3575719D1
Authority
DE
Germany
Prior art keywords
carbonylarylimidazoles
imidazolone
production
effective compositions
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585730094T
Other languages
English (en)
Inventor
Paul William Erhardt
Alfred Arthur Hagedorn Iii
Lumma, Jr
Ronald Andre Wohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of DE3575719D1 publication Critical patent/DE3575719D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8585730094T 1984-07-09 1985-07-05 Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon. Expired - Lifetime DE3575719D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/628,875 US4556665A (en) 1984-07-09 1984-07-09 Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones

Publications (1)

Publication Number Publication Date
DE3575719D1 true DE3575719D1 (de) 1990-03-08

Family

ID=24520673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585730094T Expired - Lifetime DE3575719D1 (de) 1984-07-09 1985-07-05 Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon.

Country Status (6)

Country Link
US (1) US4556665A (de)
EP (1) EP0169164B1 (de)
JP (1) JPH0649687B2 (de)
AT (1) ATE49959T1 (de)
CA (1) CA1266478A (de)
DE (1) DE3575719D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743612A (en) * 1986-10-17 1988-05-10 Berlex Laboratories, Inc. Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics
GB2352030A (en) * 1999-07-14 2001-01-17 Ibm Measuring surface roughness and contaminant thickness using ellipsometry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4447619A (en) * 1981-11-04 1984-05-08 Merrell Dow Pharmaceuticals Inc. 4-Alkanoylimidazol-2-ones
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
CA2375406C (en) * 1999-06-21 2005-10-18 The Procter & Gamble Company Processes for making granular detergent in a fluidized bed granulator having recycling of improperly sized particles

Also Published As

Publication number Publication date
ATE49959T1 (de) 1990-02-15
EP0169164A1 (de) 1986-01-22
JPS6163662A (ja) 1986-04-01
JPH0649687B2 (ja) 1994-06-29
US4556665A (en) 1985-12-03
CA1266478A (en) 1990-03-06
EP0169164B1 (de) 1990-01-31

Similar Documents

Publication Publication Date Title
ATE108453T1 (de) Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
FI98627C (fi) Menetelmä terapeuttisesti käyttökelpoisen (S)-1-(3-dimetyyliaminopropyyli)-1-(4'-fluorifenyyli)-1,3-dihydrobentsofuraani-5-karbonitriilin valmistamiseksi
HU912485D0 (en) Process for producing diazines
HUT56379A (en) Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds
DE3750733D1 (de) Verfahren zur Herstellung von Hyaluronsäure, dafür benötigte Bakterienstämme und kosmetische Zusammensetzung, welche Hyaluronsäure enthält.
DE68914488D1 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
ATE51620T1 (de) 3-(4-piperidinyl)-1,2-benzisothiazole und deren derivate, verfahren zu ihrer herstellung und verwendung als arzneimittel.
ATE159720T1 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
ATE140920T1 (de) Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
DE69627166D1 (de) Verfahren zur herstellung von 2-chlor-5-chlomethyl-thiazol-derivaten
HU9300533D0 (en) Tropolone derivatives, method for producing them medical preparatives for preventing and treating ischemic diseases containing said compounds and method for preparing them
DE59910677D1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
HUT37792A (en) Process for production of derivatives of beta-carbolin-3-carbonic acid and medical preparatives containing such compounds
HUT35680A (en) Process for preparing purine derivatives
ATE188690T1 (de) N-aryl-3-aryl-4-substituierte-4,5-dihydro-1h- pyrazol-1-carboxamide und verfahren zu deren herstellung
DE3575719D1 (de) Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
ATE106397T1 (de) Verfahren zur herstellung von 3,3- diarylacrylsäureamiden.
HUT44515A (en) Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them
HUT34478A (en) Process for producing hexahydro-pyrrolo/2.1-a/isoquinoline derivatives and pharmaceutical compositions containing them
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
DE69713666D1 (de) Zusammensetzung zum Desinfizieren von Rohstoffen, Produkten und Produktionsmitteln, Verfahren zu ihrer Herstellung, und Desinfizierungsverfahren
ATE159050T1 (de) Verfahren zur enzymatischen herstellung isomerenreiner isosorbid-2- und 5-monoester sowie deren überführung in isosorbid-2- und 5-nitrat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AG, 13353 BERLIN, DE

8339 Ceased/non-payment of the annual fee